Supplementary Table S9

Published: 8 May 2026| Version 1 | DOI: 10.17632/zj87k58nyw.1
Contributor:
Gizem S Nemutlu

Description

We evaluated three surveillance strategies: (i) no surveillance, (ii) delayed surveillance initiated at progression to compensated cirrhosis (F4), and (iii) immediate surveillance starting at F3. The file reports total costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs) for all parameter variations across these strategies.

Files

Institutions

Categories

Hepatocellular Carcinoma, Health Outcomes

Licence